Direct Conversion of Aryl Iodides to Trialkylamines via Aminomethylation: Reaction Scope, Mechanistic Studies, and Applications

Authors:

Abstract
Despite the high utility and value of trialkylamines and their derivatives, their synthesis is hindered by a limited substrate availability and non-reusable transition-metal catalysts. To that end, this study develops an aminomethylation strategy using aryl iodides and formamides while examining the substrate scope and underlying mechanism for synthesizing trialkylamines under parts-per-million-level (65 ppm) reusable palladium catalysis. This method can accommodate a wide range of substrates, including electron-rich and electrondeficient aryl, polyaryl, and heteroaryl iodides. Similarly, various formamide derivatives yield aminomethylated products. This aminomethylation strategy is used to directly synthesize biologically active molecules, such as a rivastigmine analog, and natural products, e.g., gramine. In addition, tryptamine, a serotonin receptor, and diindolylmethane, a metabolite, are successfully produced by derivatizing the aminomethylated products. Isotopelabeling experiments indicate that formamide derivatives were precursors for the reducing agent, in addition to providing both amines and carbon. A plausible catalytic pathway is proposed based on isotope-labeling experiments and density functional theory calculations, providing insights for future research and new applications in organic synthesis and medicinal chemistry.